UY26964A1 - Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal - Google Patents

Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal

Info

Publication number
UY26964A1
UY26964A1 UY26964A UY26964A UY26964A1 UY 26964 A1 UY26964 A1 UY 26964A1 UY 26964 A UY26964 A UY 26964A UY 26964 A UY26964 A UY 26964A UY 26964 A1 UY26964 A1 UY 26964A1
Authority
UY
Uruguay
Prior art keywords
erythromycin
derivatives
replaced
gastrointestinal tolerance
greater gastrointestinal
Prior art date
Application number
UY26964A
Other languages
English (en)
Inventor
Zhenkun Ma
Souming Zhang
Ly Tam Phan
Stevan Djuric
Rick F Clark
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY26964A1 publication Critical patent/UY26964A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuestos de fórmula I son útiles para el tratamiento de infeciones bacterianas pero sin producir el efecto colateral de intolerancia gastrointestinal. También se revelan composiciones que contienen los compuestos y métodos de tratamiento que los utilizan.
UY26964A 2000-10-16 2001-10-12 Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal UY26964A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24077700P 2000-10-16 2000-10-16

Publications (1)

Publication Number Publication Date
UY26964A1 true UY26964A1 (es) 2002-06-20

Family

ID=22907903

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26964A UY26964A1 (es) 2000-10-16 2001-10-12 Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal

Country Status (9)

Country Link
EP (1) EP1328534A2 (es)
JP (1) JP2004529857A (es)
AU (1) AU2002213267A1 (es)
BR (1) BR0109946A (es)
CA (1) CA2420012A1 (es)
MX (1) MXPA03003311A (es)
PE (1) PE20020522A1 (es)
UY (1) UY26964A1 (es)
WO (1) WO2002032919A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
JP2005529143A (ja) * 2002-04-30 2005-09-29 アボット・ラボラトリーズ 改良された薬物動態プロファイルを有する抗菌性化合物
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
JP2007223900A (ja) * 2004-02-03 2007-09-06 Taisho Pharmaceut Co Ltd ６−ｏ−置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd ２−フルオロ−６−ｏ−置換ケトライド誘導体
WO2007091393A1 (ja) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. １０ａ－アザライド化合物
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
CN102234302B (zh) * 2010-05-07 2014-05-07 北京理工大学 一种酮内酯衍生物、制备方法及其药物组合物
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
AU2002213267A1 (en) 2002-04-29
JP2004529857A (ja) 2004-09-30
EP1328534A2 (en) 2003-07-23
CA2420012A1 (en) 2002-04-25
MXPA03003311A (es) 2003-09-10
BR0109946A (pt) 2005-08-02
PE20020522A1 (es) 2002-06-25
WO2002032919A3 (en) 2002-09-19
WO2002032919A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
ECSP003699A (es) Inhibidores de fab i
DE60131138D1 (de) Antibakterielle mittel
NO20025954D0 (no) Glykopeptidfosfonatderivater
PA8527001A1 (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos
UY30030A1 (es) Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones
UY26964A1 (es) Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
DE60135919D1 (de) Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate
CY1107789T1 (el) Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων
DE60042401D1 (de) Fab-i inhibitoren
DE60121345D1 (de) Alkylierte imidazopyridinderivate
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
DE60127131D1 (de) Tricyclische imidazopyridine
ATE259813T1 (de) Triazolopyrimidinderivate
BRPI0412446A (pt) compostos de silicio e seu uso
DE69936052D1 (de) N1 modifizierte glycopeptide
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
PA8486101A1 (es) Derivados de higromicina
ES2164892T3 (es) Polimorfos del profarmaco 6-n-(l-ala-l-ala)-trovafloxacino.
DK1390056T3 (da) Glycopeptid-antibiotika
ATE425984T1 (de) Trizyklische antibakterielle makrolidderivate
ATE478155T1 (de) Glycopeptidantibiotika
UY27363A1 (es) Compuestos
AR023780A1 (es) Antibacterianos cetolidas
ECSP003536A (es) Derivados de rufomicina utiles como antibioticos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126